Dispersible tab/Oral susp: Zovirax Dispersible Tablets/Oral Suspension is indicated for the treatment of Herpes simplex virus infections of the skin and mucous membranes including initial and recurrent genital herpes.
Zovirax Dispersible Tablets/Oral Suspension is indicated for the suppression (prevention of recurrences) of recurrent Herpes simplex infections in immunocompetent patients.
Zovirax Dispersible Tablets/Oral Suspension is indicated for the prophylaxis of Herpes simplex infections in immunocompromised patients.
Zovirax Dispersible Tablets/Oral Suspension is indicated for the treatment of Varicella infections (chickenpox) and Herpes zoster (shingles). Studies have shown that early treatment of shingles with ZOVIRAX has a beneficial effect on pain and can reduce the incidence of post-herpetic neuralgia (zoster-associated pain).
Powd for inj: ZOVIRAX i.v. for infusion is indicated for the treatment of herpes simplex infections.
ZOVIRAX i.v. for infusion is indicated for the prophylaxis of herpes simplex infections in immune-compromised patients.
ZOVIRAX i.v. for infusion is indicated in the treatment of varicella zoster infections.
ZOVIRAX i.v. for infusion is indicated for the treatment of herpes simplex infections in the neonate.